Mary Mosher

Array ( [id] => 616286 [patent_doc_number] => 07144697 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-12-05 [patent_title] => 'Synthetic antigen for the detection of antibodies immunoreactive with HIV virus' [patent_app_type] => utility [patent_app_number] => 09/515014 [patent_app_country] => US [patent_app_date] => 2000-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6944 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/144/07144697.pdf [firstpage_image] =>[orig_patent_app_number] => 09515014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 790466 [patent_doc_number] => 06984486 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-10 [patent_title] => 'Synthetic peptide of regulatory virus protein R (VPR) of human immunodeficiency virus type 1 (HIV-1) and the utilization thereof' [patent_app_type] => utility [patent_app_number] => 09/913927 [patent_app_country] => US [patent_app_date] => 2000-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6289 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/984/06984486.pdf [firstpage_image] =>[orig_patent_app_number] => 09913927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958635 [patent_doc_number] => 06953579 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-10-11 [patent_title] => 'Chimeric virus-like particle or chimeric capsomers from BPV' [patent_app_type] => utility [patent_app_number] => 09/913204 [patent_app_country] => US [patent_app_date] => 2000-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2984 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953579.pdf [firstpage_image] =>[orig_patent_app_number] => 09913204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1065475 [patent_doc_number] => 06846665 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-25 [patent_title] => 'Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament' [patent_app_type] => utility [patent_app_number] => 09/913240 [patent_app_country] => US [patent_app_date] => 2000-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9167 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846665.pdf [firstpage_image] =>[orig_patent_app_number] => 09913240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1403868 [patent_doc_number] => 06528063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-04 [patent_title] => 'Recombinant vaccines against IBDV' [patent_app_type] => B2 [patent_app_number] => 09/477574 [patent_app_country] => US [patent_app_date] => 2000-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 7134 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528063.pdf [firstpage_image] =>[orig_patent_app_number] => 09477574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1309942 [patent_doc_number] => 06610303 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them' [patent_app_type] => B1 [patent_app_number] => 09/402016 [patent_app_country] => US [patent_app_date] => 1999-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7869 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610303.pdf [firstpage_image] =>[orig_patent_app_number] => 09402016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527909 [patent_doc_number] => 06479273 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Filtration method for separating viruses' [patent_app_type] => B1 [patent_app_number] => 09/380366 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5775 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479273.pdf [firstpage_image] =>[orig_patent_app_number] => 09380366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517071 [patent_doc_number] => 06500662 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/470661 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 24761 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500662.pdf [firstpage_image] =>[orig_patent_app_number] => 09470661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4390795 [patent_doc_number] => 06296854 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Live attenuated Venezuelan Equire encephalitis vaccine' [patent_app_type] => 1 [patent_app_number] => 9/454721 [patent_app_country] => US [patent_app_date] => 1999-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10162 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/296/06296854.pdf [firstpage_image] =>[orig_patent_app_number] => 454721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640400 [patent_doc_number] => 06395513 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Clostridial toxin derivatives able to modify peripheral sensory afferent functions' [patent_app_type] => B1 [patent_app_number] => 09/447356 [patent_app_country] => US [patent_app_date] => 1999-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8632 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395513.pdf [firstpage_image] =>[orig_patent_app_number] => 09447356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750249 [patent_doc_number] => 20030044769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'ADSORBENT FOR ELIMINATING HEPATITIS C VIRUS, ADSORBER, AND ADSORPTION METHOD' [patent_app_type] => new [patent_app_number] => 09/380644 [patent_app_country] => US [patent_app_date] => 1999-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7285 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044769.pdf [firstpage_image] =>[orig_patent_app_number] => 09380644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636711 [patent_doc_number] => 06379944 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Mammalian cell lines expressing bovine adenovirus functions' [patent_app_type] => B1 [patent_app_number] => 09/435242 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 57 [patent_no_of_words] => 34014 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379944.pdf [firstpage_image] =>[orig_patent_app_number] => 09435242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296710 [patent_doc_number] => 06251398 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Materials and methods for intracellular transport and their uses' [patent_app_type] => 1 [patent_app_number] => 9/395344 [patent_app_country] => US [patent_app_date] => 1999-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 10105 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251398.pdf [firstpage_image] =>[orig_patent_app_number] => 395344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1594029 [patent_doc_number] => 06383794 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Methods of producing high titer recombinant adeno-associated virus' [patent_app_type] => B1 [patent_app_number] => 09/379841 [patent_app_country] => US [patent_app_date] => 1999-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 26 [patent_no_of_words] => 13030 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383794.pdf [firstpage_image] =>[orig_patent_app_number] => 09379841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1564112 [patent_doc_number] => 06375952 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Immunological herpes simplex virus antigens and methods for use thereof' [patent_app_type] => B1 [patent_app_number] => 09/368770 [patent_app_country] => US [patent_app_date] => 1999-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 19095 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/375/06375952.pdf [firstpage_image] =>[orig_patent_app_number] => 09368770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4376779 [patent_doc_number] => 06277416 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Pesticides comprising benzophenanthridine alkaloids' [patent_app_type] => 1 [patent_app_number] => 9/662381 [patent_app_country] => US [patent_app_date] => 1999-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4700 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277416.pdf [firstpage_image] =>[orig_patent_app_number] => 662381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4261852 [patent_doc_number] => 06306400 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis' [patent_app_type] => 1 [patent_app_number] => 9/362831 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 14882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306400.pdf [firstpage_image] =>[orig_patent_app_number] => 362831 [rel_patent_id] =>[rel_patent_doc_number] =>)